These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

288 related articles for article (PubMed ID: 16242027)

  • 1. Systemic and local antibiotic prophylaxis in the prevention of Staphylococcus epidermidis graft infection.
    Turgut H; Sacar S; Kaleli I; Sacar M; Goksin I; Toprak S; Asan A; Cevahir N; Tekin K; Baltalarli A
    BMC Infect Dis; 2005 Oct; 5():91. PubMed ID: 16242027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prophylactic efficacy of rifampicin-soaked graft in combination with systemic vancomycin in the prevention of prosthetic vascular graft infection: an experimental study.
    Sacar M; Goksin I; Baltalarli A; Turgut H; Sacar S; Onem G; Ozcan V; Adali F
    J Surg Res; 2005 Dec; 129(2):329-34. PubMed ID: 16360378
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of rifampin-levofloxacin as a prophylactic agent in preventing Staphylococcus epidermidis graft infection.
    Ghiselli R; Giacometti A; Goffi L; Cirioni O; Boccoli G; Mocchegiani F; Riva A; Scalise G; Saba V
    Eur J Vasc Endovasc Surg; 2000 Dec; 20(6):508-11. PubMed ID: 11136585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Linezolid alone and in combination with rifampicin prevents experimental vascular graft infection due to methicillin-resistant Staphylococcus aureus and Staphylococcus epidermidis.
    Sacar M; Sacar S; Kaleli I; Onem G; Turgut H; Goksin I; Ozcan V; Kaan Inan B; Duver H; Baltalarli A
    J Surg Res; 2007 May; 139(2):170-5. PubMed ID: 17292421
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of vancomycin, teicoplanin and fusidic acid as prophylactic agents in prevention of vascular graft infection: an experimental study in rat.
    Yasim A; Gul M; Atahan E; Ciragil P; Aral M; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Mar; 31(3):274-9. PubMed ID: 16360328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. RNAIII-inhibiting peptide and/or nisin inhibit experimental vascular graft infection with methicillin-susceptible and methicillin-resistant Staphylococcus epidermidis.
    Ghiselli R; Giacometti A; Cirioni O; Dell'Acqua G; Mocchegiani F; Orlando F; D'Amato G; Rocchi M; Scalise G; Saba V
    Eur J Vasc Endovasc Surg; 2004 Jun; 27(6):603-7. PubMed ID: 15121110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular graft infection by Staphylococcus aureus: efficacy of cefazolin, teicoplanin and vancomycin prophylaxis protocols in a rat model.
    Atahan E; Gul M; Ergun Y; Eroglu E
    Eur J Vasc Endovasc Surg; 2007 Aug; 34(2):182-7. PubMed ID: 17481929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prophylaxis against Staphylococcus aureus vascular graft infection with mupirocin-soaked, collagen-sealed dacron.
    Ghiselli R; Giacometti A; Goffi L; Cirioni O; Mocchegiani F; Orlando F; Paggi AM; Petrelli E; Scalise G; Saba V
    J Surg Res; 2001 Aug; 99(2):316-20. PubMed ID: 11469904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Vascular graft infection by Staphylococcus epidermidis: efficacy of various perioperative prophylaxis protocols in an animal model].
    Giacometti A; Cirioni O; Ghiselli R; Mocchegiani F; Riva A; Saba V; Scalise G
    Infez Med; 2001 Mar; 9(1):13-8. PubMed ID: 12082344
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local application of vancomycin for prophylaxis of graft infection: release of vancomycin from antibiotic-bonded Dacron grafts, toxicity in endothelial cell culture, and efficacy against graft infection in an animal model.
    Muhl E; Gatermann S; Iven H; Dendorfer A; Bruch HP
    Ann Vasc Surg; 1996 May; 10(3):244-53. PubMed ID: 8792993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinupristin/dalfopristin bonding in combination with intraperitoneal antibiotics prevent infection of knitted polyester graft material in a subcutaneous rat pouch model infected with resistant Staphylococcus epidermidis.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Del Prete M; D'Amato G; Scalise G; Saba V
    Eur J Vasc Endovasc Surg; 2002 Sep; 24(3):230-4. PubMed ID: 12217284
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prophylactic efficacy of linezolid alone or combined with levofloxacin and vancomycin in a rat subcutaneous pouch model of graft infection caused by Staphylococcus epidermidis with intermediate resistance to glycopeptides.
    Giacometti A; Ghiselli R; Cirioni O; Mocchegiani F; Orlando F; Del Prete MS; D'Amato G; Silvestri C; Saba V; Scalise G
    J Antimicrob Chemother; 2003 Oct; 52(4):724-6. PubMed ID: 12951347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temporin A as a prophylactic agent against methicillin sodium-susceptible and methicillin sodium-resistant Staphylococcus epidermidis vascular graft infection.
    Ghiselli R; Giacometti A; Cirioni O; Mocchegiani F; Orlando F; Kamysz W; Del Prete MS; Lukasiak J; Scalise G; Saba V
    J Vasc Surg; 2002 Nov; 36(5):1027-30. PubMed ID: 12422090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 1999 Sep; 18(3):225-32. PubMed ID: 10688422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polycationic peptides as prophylactic agents against methicillin-susceptible or methicillin-resistant Staphylococcus epidermidis vascular graft infection.
    Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V
    Antimicrob Agents Chemother; 2000 Dec; 44(12):3306-9. PubMed ID: 11083632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatin-sealed dacron graft is not more susceptible to MRSA infection than PTFE graft.
    Yasim A; Gul M; Ciralik H; Ergun Y
    Eur J Vasc Endovasc Surg; 2006 Oct; 32(4):425-30. PubMed ID: 16725356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does in situ replacement of a staphylococcal infected vascular graft with a rifampicin impregnated gelatin sealed Dacron graft reduce the incidence of subsequent infection?
    Vicaretti M; Hawthorne W; Ao PY; Fletcher JP
    Int Angiol; 2000 Jun; 19(2):158-65. PubMed ID: 10905800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of polycationic peptides in preventing vascular graft infection due to Staphylococcus epidermidis.
    Giacometti A; Cirioni O; Ghiselli R; Goffi L; Mocchegiani F; Riva A; Scalise G; Saba V
    J Antimicrob Chemother; 2000 Nov; 46(5):751-6. PubMed ID: 11062194
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of quinupristin-dalfopristin in preventing vascular graft infection due to Staphylococcus epidermidis with intermediate resistance to glycopeptides.
    Giacometti A; Cirioni O; Ghiselli R; Orlando F; Mocchegiani F; Riva A; Del Prete MS; Saba V; Scalise G
    Antimicrob Agents Chemother; 2002 Sep; 46(9):2885-8. PubMed ID: 12183242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic efficacy of topical temporin A and RNAIII-inhibiting peptide in a subcutaneous rat Pouch model of graft infection attributable to staphylococci with intermediate resistance to glycopeptides.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Gov Y; Kamysz W; Lukasiak J; Mocchegiani F; Orlando F; D'Amato G; Balaban N; Saba V; Scalise G
    Circulation; 2003 Aug; 108(6):767-71. PubMed ID: 12885754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.